Handelsbanken Fonder’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $711K | Hold |
22,700
| – | – | ﹤0.01% | 1098 |
|
|
2025
Q1 | $762K | Hold |
22,700
| – | – | ﹤0.01% | 1058 |
|
|
2024
Q4 | $890K | Hold |
22,700
| – | – | ﹤0.01% | 1025 |
|
|
2024
Q3 | $894K | Buy |
22,700
+1,700
| +8% | +$67K | ﹤0.01% | 994 |
|
|
2024
Q2 | $819K | Buy |
21,000
+6,900
| +49% | +$269K | ﹤0.01% | 921 |
|
|
2024
Q1 | $607K | Hold |
14,100
| – | – | ﹤0.01% | 1070 |
|
|
2023
Q4 | $649K | Hold |
14,100
| – | – | ﹤0.01% | 999 |
|
|
2023
Q3 | $482K | Hold |
14,100
| – | – | ﹤0.01% | 1070 |
|
|
2023
Q2 | $543K | Hold |
14,100
| – | – | ﹤0.01% | 1027 |
|
|
2023
Q1 | $505K | Hold |
14,100
| – | – | ﹤0.01% | 1004 |
|
|
2022
Q4 | $556K | Buy |
14,100
+3,500
| +33% | +$138K | ﹤0.01% | 915 |
|
|
2022
Q3 | $383K | Sell |
10,600
-4,600
| -30% | -$166K | ﹤0.01% | 1106 |
|
|
2022
Q2 | $462K | Sell |
15,200
-2,400
| -14% | -$72.9K | ﹤0.01% | 1072 |
|
|
2022
Q1 | $538K | Sell |
17,600
-3,100
| -15% | -$94.8K | ﹤0.01% | 1150 |
|
|
2021
Q4 | $647K | Buy |
+20,700
| New | +$647K | ﹤0.01% | 1175 |
|